Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $263 | In Stock | |
5 mg | $662 | In Stock | |
10 mg | $1,060 | In Stock | |
25 mg | $1,570 | In Stock | |
50 mg | $2,120 | In Stock | |
100 mg | $2,860 | In Stock |
Description | Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity. |
In vitro | b>METHODS: Bimagrumab (Anti-ACVR2B Reference Antibody) (1 pM-1 μM) was used to treat HEK293 cells and its potency in inhibiting ActRII ligand signaling was evaluated in a Smad2/3 CAGA-luciferase reporter assay. RESULTS: Bimagrumab (Anti-ACVR2B Reference Antibody) showed similar dose-dependent inhibition of activin A-induced luciferase with an IC50 value of 343 ± 97 pM. [1] |
In vivo | b>METHODS: Bimagrumab (Anti-ACVR2B Reference Antibody) (6, 20 mg/kg, subcutaneous injection) was used to treat mice and body weight was measured weekly to study its use in naive mice. RESULTS: Bimagrumab promoted weight gain and skeletal muscle hypertrophy in all examined mouse muscles, including slow, fast, and mixed muscles. [1] |
Alias | LY-3985863, LY3985863, LY 3985863, BYM-338, BYM338, BYM 338, Anti-ACVR2B Reference Antibody |
Molecular Weight | 142.78 kDa |
Cas No. | 1356922-05-8 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.